MA5-13473

antibody from Invitrogen Antibodies

Targeting: CD8B CD8B1

Antibody data

Submit

Validation data

Product number: MA5-13473 - Provider product page
Provider: Invitrogen Antibodies
Product name: CD8 alpha Monoclonal Antibody (C8/144B)
Antibody type: Monoclonal
Antigen: Synthetic peptide
Description: MA5-13473 targets CD8 in IHC (P) and FACSs applications and shows reactivity with Human samples.
Antibody clone number: C8/144B
Concentration: 0.5 mg/mL

CD8B protein structure - MA5-13473 shown in red.

Supportive validation

Supportive validation

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Fig. 2 Immuno-FISH and CD8+ T-cell infiltrate in primary vs. metastatic samples. a iFISH images of one area of the primary tumor and brain and liver metastases of case 15. Scale bar 100 mm. b Dot plot depicting relative frequencies of the four different cell types in primary and metastatic samples. Error bars, S.E.M. c Immunofluorescence analysis of CD8, GranzymeB (GZMB), and pSTAT3. Images are a montage of nine fields captured from one area of the tissue. Scale bar 100 mm. d , e Graph depicting numbers of CD8 + T cells per montage ( d ) and fraction of GZMB + CD8 + T cells ( e ). Significance of the difference between primary and metastatic samples was calculated using the Wilcoxon rank-sum test. f Correlation analysis between the number of infiltrating CD8 + T cells and the relative frequencies of specific cell populations in primary and metastatic samples. g Correlation analysis between number of infiltrating CD8 + T cells and the Shannon index of diversity in all, primary and metastatic samples. Gray area, 95% confidence interval. Sample sizes were n = 16 primary tumors and n = 18 metastases

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 1. Immunohistochemical analyses of intratumoral and peritumoral lymphocytes. Immunohistochemical staining of tumor-infiltrating (A) Foxp3 + T cells and (B) CD8 + T lymphocytes in invasive breast cancer. A diffuse pattern of intratumoral lymphocytes was observed. By contrast, peritumoral lymphocytes formed a lymphoid aggregate (x10 objective lens). There were markedly more Foxp3 + Tregs in the (C) peritumoral area than the (E) intratumoral areas. There was an increased number of CD8 + lymphocytes in the (D) peritumoral area than the (F) intratumoral areas. A and B, x10 objective lens; B-E, x40 objective lens. CD, cluster of differentiation; Foxp3, forkhead box 3.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 3 UVR-induced inflammation recruits and maintains CD8 + GATA3 + T cells 14 days post-UVR . (a) Quantification of the total number of CD8 + cells on immunohistochemical staining ( N = 12 or 13 healthy volunteers for each time point). (b) Percentage of CD8 + GATA3 + cells of total CD8 + cells by immunofluorescence analysis ( N = 8 healthy volunteers for each time point). (c) Representative immunofluorescent images of CD8 + GATA3 + cells post-UVR. Data are mean +- SEM. Experiments were performed once. Scale bars = 50 um. * P < 0.05, ** P < 0.01, *** P < 0.001.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Fig. 3 Transcriptomic analysis demonstrates considerable ITH underlying convergent immune phenotypes. a Volcano plot of differentially expressed genes comparing high vs. low immune infiltrate regions across the tumor core and margins. Vertical red lines indicate a minimum twofold change in expression value; horizontal red line indicates the adjusted p -value threshold of

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 1 Matched haematoxylin & eosin (H&E) stained sections and multiplexed immunofluorescence (mIF) images from TMA cores of 2 patients tumours stained using Opal reagents: CD3 white, CD8 pink, CD20 orange, CD68 purple, PD-1 turquoise, PD-L1 yellow, FoxP3 green and Pan-CK red. DAPI nuclear counterstain is dark blue.. Patient 1 ( A - D ) & patient 2 ( E - H ) ( A , E : H&E x 200; B , F: mIF x 200; C and G: mIF x 400; D and H: H&E x 400).